• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗合成酶综合征伴发肺动脉高压和恶性肿瘤复发。

Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy.

机构信息

Department of Rheumatology, Kobe City Medical Center General Hospital, Japan.

Department of General Internal Medicine, Kobe City Medical Center General Hospital, Japan.

出版信息

Intern Med. 2023 Sep 15;62(18):2747-2751. doi: 10.2169/internalmedicine.1275-22. Epub 2023 Feb 8.

DOI:10.2169/internalmedicine.1275-22
PMID:36754403
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10569925/
Abstract

A 69-year-old man with a history of anti-synthetase antibody-positive polymyositis and interstitial lung disease (ILD) stable for more than 20 years suddenly developed pulmonary artery hypertension (PAH) with a mean PA pressure of 46 mmHg. At this stage, ILD was mild, but it became acutely exacerbated later, and high-dose corticosteroid and intravenous cyclophosphamide ameliorated both PAH and ILD. The tricuspid regurgitation pressure gradient decreased from 80 to 49 mmHg and ILD recovered almost completely. During a systemic examination, bone metastatic cancer of unknown origin was found. We herein report the relationship between anti-synthetase syndrome (ASS) and PAH as well as ASS and malignancy.

摘要

一位 69 岁男性,有抗合成酶抗体阳性多发性肌炎和间质性肺病(ILD)病史 20 余年,病情稳定。患者突然出现肺动脉高压(PAH),平均肺动脉压为 46mmHg。此时ILD 处于轻度阶段,但后来急剧恶化,高剂量皮质类固醇和静脉环磷酰胺改善了 PAH 和ILD。三尖瓣反流压力梯度从 80mmHg 降至 49mmHg,ILD 几乎完全恢复。在全身检查中,发现不明来源的骨转移性癌。我们在此报告抗合成酶综合征(ASS)与 PAH 以及 ASS 与恶性肿瘤之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/fd6d45355eed/1349-7235-62-2747-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/b8580b8bf681/1349-7235-62-2747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/7315e1f05000/1349-7235-62-2747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/5da5df9706ec/1349-7235-62-2747-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/fd6d45355eed/1349-7235-62-2747-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/b8580b8bf681/1349-7235-62-2747-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/7315e1f05000/1349-7235-62-2747-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/5da5df9706ec/1349-7235-62-2747-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6d6/10569925/fd6d45355eed/1349-7235-62-2747-g004.jpg

相似文献

1
Anti-synthetase Syndrome That Relapsed with Pulmonary Arterial Hypertension and Malignancy.抗合成酶综合征伴发肺动脉高压和恶性肿瘤复发。
Intern Med. 2023 Sep 15;62(18):2747-2751. doi: 10.2169/internalmedicine.1275-22. Epub 2023 Feb 8.
2
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压与系统性硬化症相关肺动脉高压患者治疗后血流动力学反应及结局比较:特发性肺纤维化相关肺动脉高压预后因素研究数据。
Arthritis Rheumatol. 2021 Feb;73(2):295-304. doi: 10.1002/art.41512. Epub 2020 Dec 29.
3
Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy.经外科肺活检病理证实的抗甘氨酰tRNA合成酶(抗EJ)抗体相关间质性肺疾病的长期临床病程
BMC Pulm Med. 2016 Dec 1;16(1):168. doi: 10.1186/s12890-016-0325-y.
4
Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.中国系统性硬化症相关毛细血管前肺动脉高压患者的临床表型、血液动力学特征和预后:一项回顾性研究。
Clin Rheumatol. 2022 Jun;41(6):1675-1686. doi: 10.1007/s10067-021-06016-8. Epub 2022 Jan 31.
5
Acute pulmonary arterial hypertension associated with anti-synthetase syndrome.与抗合成酶综合征相关的急性肺动脉高压
Scand J Rheumatol. 2010 Mar;39(2):179-80. doi: 10.3109/03009740903270615.
6
Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.肺动脉高压是弥漫性系统性硬化症的一个主要死亡因素,与间质性肺病无关。
Arthritis Rheum. 2006 Jan;54(1):184-91. doi: 10.1002/art.21538.
7
Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.间质性肺疾病会增加合并肺动脉高压的系统性硬化症患者的死亡率,而不影响血流动力学和运动能力。
Clin Rheumatol. 2017 Feb;36(2):381-390. doi: 10.1007/s10067-016-3504-6. Epub 2016 Dec 27.
8
Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.抗合成酶综合征患者连续 HRCT 时的间质性肺病进展的预后因素。
Eur Radiol. 2019 Oct;29(10):5349-5357. doi: 10.1007/s00330-019-06152-5. Epub 2019 Mar 27.
9
Rituximab treatment of the anti-synthetase syndrome: a retrospective case series.利妥昔单抗治疗抗合成酶综合征:一项回顾性病例系列研究。
Rheumatology (Oxford). 2009 Aug;48(8):968-71. doi: 10.1093/rheumatology/kep157. Epub 2009 Jun 16.
10
Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.平均肺动脉压作为结缔组织病相关间质性肺疾病的预后指标:一项回顾性队列研究。
BMC Pulm Med. 2016 Apr 19;16(1):55. doi: 10.1186/s12890-016-0207-3.

本文引用的文献

1
Antisynthetase syndrome - much more than just a myopathy.抗合成酶综合征——远不止一种肌病。
Semin Arthritis Rheum. 2021 Feb;51(1):72-83. doi: 10.1016/j.semarthrit.2020.09.020. Epub 2020 Dec 22.
2
Antisynthetase syndrome and pulmonary hypertension: report of two cases and review of the literature.抗合成酶综合征与肺动脉高压:两例报告及文献综述
Mod Rheumatol Case Rep. 2021 Jan;5(1):152-155. doi: 10.1080/24725625.2020.1794521. Epub 2020 Jul 22.
3
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
4
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study.在特发性炎性肌病中鉴定多种与癌症相关的肌炎特异性自身抗体:一项大型纵向队列研究。
Arthritis Res Ther. 2017 Nov 25;19(1):259. doi: 10.1186/s13075-017-1469-8.
5
Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature.与抗Jo1合成酶综合征相关的肺鳞状细胞癌:一例报告并文献复习
Rheumatol Int. 2017 Jul;37(7):1203-1206. doi: 10.1007/s00296-017-3728-z. Epub 2017 Apr 26.
6
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodies.抗合成酶综合征的纵向队列研究:黑人患者以及抗PL7和抗PL12自身抗体患者间质性肺疾病严重程度增加
Rheumatology (Oxford). 2017 Jun 1;56(6):999-1007. doi: 10.1093/rheumatology/kex021.
7
Pulmonary tumor thrombotic microangiopathy associated with urothelial carcinoma of the urinary bladder: antemortem diagnosis by pulmonary microvascular cytology.与膀胱尿路上皮癌相关的肺肿瘤血栓性微血管病:通过肺微血管细胞学进行生前诊断
Clin Case Rep. 2015 Sep;3(9):735-9. doi: 10.1002/ccr3.330. Epub 2015 Jul 29.
8
Pulmonary hypertension in chronic lung diseases.慢性肺部疾病相关肺动脉高压。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D109-16. doi: 10.1016/j.jacc.2013.10.036.
9
Pulmonary arterial hypertension in antisynthetase syndrome without myositis.无肌炎的抗合成酶综合征中的肺动脉高压
Tuberk Toraks. 2013;61(2):170-3. doi: 10.5578/tt.5042.
10
Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival.抗合成酶综合征相关肺动脉高压:患病率、病因和生存率。
Eur Respir J. 2013 Nov;42(5):1271-82. doi: 10.1183/09031936.00156312. Epub 2013 Feb 8.